# Sato Pharmaceutical Co., Ltd. – FDA Inspection, Nov 21, 2025

Source: https://www.keypedia.com/records/fda_inspections/sato-pharmaceutical-co-ltd/78dc6783-6b60-4d11-99c6-bd1e12334c10
Source feed: FDA_Inspections

> FDA inspection 1292356 of Sato Pharmaceutical Co., Ltd., November 21, 2025. Classification: Official Action Indicated (OAI). 10 citations under 21 CFR part 211. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1292356
- Company Name: Sato Pharmaceutical Co., Ltd.
- Inspection Date: 2025-11-21
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 10

## Related Documents

- [FDA Inspection 1111704 - 2019-11-07](https://www.keypedia.com/records/fda_inspections/sato-pharmaceutical-co-ltd/f303b0c8-052c-479f-a5eb-cee80b3d9998)
- [FDA Inspection 1107699 - 2019-10-25](https://www.keypedia.com/records/fda_inspections/sato-pharmaceutical-co-ltd/eb00e326-37ea-4419-aaed-a041aad13d5a)
- [FDA Inspection 1064716 - 2018-07-03](https://www.keypedia.com/records/fda_inspections/sato-pharmaceutical-co-ltd/9a4b8420-d982-428c-88b5-2785907b264c)
- [FDA Inspection 961508 - 2016-02-12](https://www.keypedia.com/records/fda_inspections/sato-pharmaceutical-co-ltd/7220a26f-ea4c-4152-b9aa-a7142357e82f)
- FDA Inspection 808343 - 2012-11-16

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/anastasia-m-shields/a22b8d52-e3f9-4e61-aa3f-6f03ff2f59df)
- [Investigator](https://www.keypedia.com/people/nibin-varghese/43e17f63-2c1f-4d46-b26f-dc8ac8885438)

Company: https://www.keypedia.com/companies/sato-pharmaceutical-co-ltd/5e274c7f-ada5-44d9-8c9b-068c7392b4ea

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8
